Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Andersson K-E - Lower urinary tract symptoms (LUTS), overactive bladder syndrome (OAB) and detrusor overactivity (DO) are all conditions that can have major effects on quality of life and social functioning. Antimuscarinic drugs are first-line treatment-they often have good initial response rates, but adverse effects and decreasing efficacy cause long-term compliance problems, and alternatives are needed.


Today in Bladder...keeping you current

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Today in Clinical Pharmacology...keeping you current

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Today in Voiding Dys/Incontinence...keeping you current

Alpha blockers prior to removal of a catheter for acute urinary retention in adult men
Cochrane Reviews, 10/19/09

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address